Advertisement

Behçet's Syndrome

  • Hasan Yazici
  • Yusuf Yazici

Abstract

The prevalence of Behçet's syndrome is highest in countries of the eastern Mediterranean, the Middle East, and East Asia. Aphthous oral ulcers are usually the first and most persistent clinical feature of Behçet's syndrome. Aphthous ulcers also occur frequently on the genitals (e.g., the scrotum or vulva). Uveitis — most frequently a bilateral panuveitis is common in Behçet's syndrome. Eye disease constitutes a major source of morbidity. Many forms of central nervous system disease may occur in Behçet's syndrome. These include dural sinus thrombi and white matter lesions in the midbrain and brainstem. Unlike other vasculitides, however, peripheral nervous system disease is rare. HLA-B51 is a risk factor for Behçet's syndrome.

Keywords

Deep Venous Thrombosis Intermittent Claudication Polyarteritis Nodosa Reactive Arthritis Oral Ulcer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Ahn JK, Lee YS, Jeon CH, et al. Treatment of venous thrombosis associated with Behçet's disease: Immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation. Clin Rheumatol 2008; 27:201–205PubMedCrossRefGoogle Scholar
  2. Aktulga E, Altac M, Muftuoglu A, et al A double blind study of colchi-cine in Behçet's disease. Haematologica 1980; 65:399–402PubMedGoogle Scholar
  3. Azizlerli G, Kose AA, Sarica R, et al Prevalence of Behçet's disease in Istanbul, Turkey. Int J Dermatol 2003; 42:803–806CrossRefGoogle Scholar
  4. Brezniak N, Shtrasburg S, Langevitz P, et al Serum IgD as a discriminator between the two periodic febrile syndromes hyperimmunoglobulinaemia D syndrome and Behçet's disease. Ann Rheum Dis 1998; 57:255–256PubMedCrossRefGoogle Scholar
  5. Diri E, Mat C, Hamuryudan V, et al Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: A controlled and masked study. Ann Rheum Dis 2001; 60:1074–1076PubMedCrossRefGoogle Scholar
  6. Ergun T, Gurbuz O, Dogusoy G, et al Histopathologic features of the spontaneous pustular lesions of Behçet's syndrome. Int J Dermatol 1998; 37:194–196PubMedCrossRefGoogle Scholar
  7. Erkan D, Yazici Y, Sanders A, et al Is Hughes-Stovin syndrome Behçet's disease? Clin Exp Rheumatol 2004; 22(4 Suppl 34):S64–S68PubMedGoogle Scholar
  8. Fresko I, Ugurlu S, Ozbakir F, et al Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome. Clin Exp Rheumatol 2005; 23(4 Suppl 38):S67–S70PubMedGoogle Scholar
  9. Günaydin I, Ustündag? C, Kaner G, et al The prevalence of Sjögren's syndrome in Behçet's syndrome. J Rheumatol 1994; 21:1662–1664PubMedGoogle Scholar
  10. Hamuryudan V, Ozyazgan Y, Hizli N, et al Azathioprine in Behçet's syndrome: Effects on long-term prognosis. Arthritis Rheum 1997; 40:769–774PubMedCrossRefGoogle Scholar
  11. Hamuryudan V, Er T, Seyahi E, et al Pulmonary artery aneurysms in Behçet syndrome. Am J Med 2004; 117:867–870PubMedCrossRefGoogle Scholar
  12. Hatemi G, Bahar H, Uysal S, et al The pustular skin lesions in Behçet's syndrome are not sterile. Ann Rheum Dis 2004; 63:1450–1452PubMedCrossRefGoogle Scholar
  13. Hatemi G, Fresko I, Tascilar K, et al Increased enthesopathy among Behçet's syndrome patients with acne and arthritis: An ultrasonog-raphy study. Arthritis Rheum 2008; 58:1539–1545PubMedCrossRefGoogle Scholar
  14. Hirohata S. Histopathology of central nervous system lesions in Behçet's disease. J Neurol Sci 2008; 267:1–2CrossRefGoogle Scholar
  15. Inanc N, Mumcu G, Birtas E, et al Serum mannose-binding lectin levels are decreased in Behçet's disease and associated with disease severity. J Rheumatol 2005; 32:287–291PubMedGoogle Scholar
  16. International Study Group for Behcet's disease. Criteria for diagnosis of Behcet's disease. Lancet 1990; 335:1078–1080Google Scholar
  17. Kahraman O, Celebi-Onder S, Kamali S, et al Long-term course of deep venous thrombosis in patients with Behçet's disease. Arthritis Rheum 2003; 48 (Suppl):S385Google Scholar
  18. Kural-Seyahi E, Fresko I, Seyahi, et al The long-term mortality and morbidity of Behçet syndrome: AN 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003; 82:60–76Google Scholar
  19. Mahr A, Guillevin L, Poissonnet M, et al Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: A capture-recapture estimate. Arthritis Rheum 2004; 51:92–99PubMedCrossRefGoogle Scholar
  20. Mahr A, Belarbi L, Wechsler W, et al Population-based study of Behçet's disease: Differences by ethnic origin and low variation by age at migration. Arthritis Rheum 2008; 58:3951–9 (in press)Google Scholar
  21. Pipitone N, Boiardi L, Olivieri, et al Clinical manifestations of Behçet's disease in 137 Italian patients: Results of a multicenter study. Clin Exp Rheumatol 2004; 22(Suppl 36):S46–S51PubMedGoogle Scholar
  22. Seyahi E, Memisoglu E, Hamuryudan, et al Coronary atherosclerosis in Behçet's syndrome: A pilot study using electron-beam computed tomography. Rheumatology (Oxford) 2004; 43: 1448–1450CrossRefGoogle Scholar
  23. Sakane T, Takeno M, Suzuki N, et al Behçet's disease. N Engl J Med 1999; 341:1284–1291. Arthritis Rheum 2008 (in press)PubMedCrossRefGoogle Scholar
  24. Siva A, Yazici H. Behcet's Disease. In: Levine S, Doruk E (eds) Handbook of systemic autoimmune diseases, neurology volume [The Neurologic Involvement in Systemic Autoimmune Disorders]. New York, Elsevier Science, 2004, pp. 193–216Google Scholar
  25. Tunc R, Keyman E, Melikoglu M, et al Target organ associations in Turkish patients with Behçet's disease: A cross sectional study by exploratory factor analysis. J Rheumatol 2002; 29: 2393–2396PubMedGoogle Scholar
  26. Tunc R, Saip S, Siva A, et al Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome. Ann Rheum Dis 2004; 63:1693–1694PubMedCrossRefGoogle Scholar
  27. Tüzün B, Tüzün Y, Yurdakul, et al Neutrophil chemotaxis in Behçet's syndrome. Ann Rheum Dis 1999; 58:658Google Scholar
  28. Ugurlu S, Seyahi E, Yazici H. Prevalence of angina, myocardial infarction and intermittent claudication assessed by Rose Questionnaire among patients with Behçet's syndrome. Rheumatology (Oxford) 2008; 47(4):472–475CrossRefGoogle Scholar
  29. Yazici Y, Moses N. Clinical manifestations and ethnic background of patients with Behçet's syndrome in a US cohort. Arthritis Rheum 2007; 56:S502Google Scholar
  30. Yazici H, Pazarli H, Barnes CG, et al A controlled trial of azathio-prine in Behçet's syndrome. N Engl J Med 1990; 322: 281–285PubMedCrossRefGoogle Scholar
  31. Yurdakul S, Mat C, Tuzun Y, et al. Double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum 2001; 44:2686–2692PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Hasan Yazici
    • 1
  • Yusuf Yazici
    • 2
  1. 1.University of Istanbul/Cerrahpasa Medical FacultyDivision of Rheumatology, Department of MedicineKadikoyTurkey
  2. 2.New York UniversityHospital for Joint Diseases Division of Rheumatology 246New YorkUSA

Personalised recommendations